Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Margel

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Urology|March 20, 2020
Short-Term Outcomes of Active Surveillance for Low Risk Prostate Cancer among Men with Germline DNA Repair Gene MutationsDaniel Halstuch, Yaara Ber, Daniel Kedar, et al.
Biomaterials|July 24, 2007
Radiopaque iodinated polymeric nanoparticles for X-ray imaging applicationsAnna Galperin, David Margel, Jack Baniel, et al.
The Journal of Urology|July 28, 2020
Reply by AuthorsDaniel Halstuch, Yaara Ber, Daniel Kedar, et al.
The Journal of Urology|March 7, 2006
Prediction of extravesical disease by preoperative serum markers in patients with clinically organ confined invasive bladder cancerDavid Margel, Raanan Tal, Avivit Neuman, et al.
BMJ (Clinical Research Ed.)|April 17, 2013
Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE studyPaul Toren, David Margel, Girish Kulkarni, et al.
European Urology|December 20, 2016
Corrigendum to "Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer" [Eur Urol 2011;59:113-9]David Margel, Meirav Pevsner-Fischer, Jack Baniel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 6, 2012
Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostateSeetha Venkateswaran, David Margel, Stanley Yap, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 28, 2015
Time from first detectable PSA following radical prostatectomy to biochemical recurrence: A competing risk analysisLeonora de Boo, Melania Pintilie, Paul Yip, et al.
Urology|October 2, 2007
Predictors of nocturia quality of life before and shortly after prostatectomyDavid Margel, David Lifshitz, Nava Brown, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2020
Patients treated for uric acid stones reoccur more often and within a shorter interval compared to patients treated for calcium stonesAmihay Nevo, Oleg Levi, Ami Sidi, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Urology|March 20, 2020
Short-Term Outcomes of Active Surveillance for Low Risk Prostate Cancer among Men with Germline DNA Repair Gene MutationsDaniel Halstuch, Yaara Ber, Daniel Kedar, et al.
Biomaterials|July 24, 2007
Radiopaque iodinated polymeric nanoparticles for X-ray imaging applicationsAnna Galperin, David Margel, Jack Baniel, et al.
The Journal of Urology|July 28, 2020
Reply by AuthorsDaniel Halstuch, Yaara Ber, Daniel Kedar, et al.
The Journal of Urology|March 7, 2006
Prediction of extravesical disease by preoperative serum markers in patients with clinically organ confined invasive bladder cancerDavid Margel, Raanan Tal, Avivit Neuman, et al.
BMJ (Clinical Research Ed.)|April 17, 2013
Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE studyPaul Toren, David Margel, Girish Kulkarni, et al.
European Urology|December 20, 2016
Corrigendum to "Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer" [Eur Urol 2011;59:113-9]David Margel, Meirav Pevsner-Fischer, Jack Baniel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 6, 2012
Comparison of serum testosterone levels in prostate cancer patients receiving LHRH agonist therapy with or without the removal of the prostateSeetha Venkateswaran, David Margel, Stanley Yap, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 28, 2015
Time from first detectable PSA following radical prostatectomy to biochemical recurrence: A competing risk analysisLeonora de Boo, Melania Pintilie, Paul Yip, et al.
Urology|October 2, 2007
Predictors of nocturia quality of life before and shortly after prostatectomyDavid Margel, David Lifshitz, Nava Brown, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2020
Patients treated for uric acid stones reoccur more often and within a shorter interval compared to patients treated for calcium stonesAmihay Nevo, Oleg Levi, Ami Sidi, et al.
Pageof 11